4//SEC Filing
Nau Jeffrey 4
Accession 0001209191-22-059794
CIK 0001720725other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:36 PM ET
Size
6.2 KB
Accession
0001209191-22-059794
Insider Transaction Report
Form 4
Nau Jeffrey
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2022-12-01$11.20/sh−6,217$69,630→ 151,381 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units (the "RSUs"). Such RSUs were previously reported on the Reporting Person's Form 4 as to (i) 25,898 filed with the Securities and Exchange Commission on February 2, 2021 (the "2021 Award"); and (ii) 46,700 filed with the Securities and Exchange Commission on January 11, 2022 (the "2022 Award"). 6,474 RSUs of the 2021 Award and 11,675 RSUs of the 2022 Award were subsequently accelerated, effective December 1, 2022, resulting in the withholding being reported herein.
- [F2]These shares are held by the Reporting Person's spouse.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001791159
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:36 PM ET
- Size
- 6.2 KB